• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膦酸酯前药:概述及最新进展。

Phosphonate prodrugs: an overview and recent advances.

机构信息

Department of Chemistry, George Washington University, Washington, DC 20052, USA.

出版信息

Future Med Chem. 2019 Jul;11(13):1625-1643. doi: 10.4155/fmc-2018-0591.

DOI:10.4155/fmc-2018-0591
PMID:31469328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6722485/
Abstract

Phosphonates, often used as isosteric replacements for phosphates, can provide important interactions with an enzyme. Due to their high charge at physiological pH, however, permeation into cells can be a challenge. Protecting phosphonates as prodrugs has shown promise in drug delivery. Thus, a variety of structures and cleavage/activation mechanisms exist, enabling release of the active compound. This review describes the structural diversity of these pro-moieties, relevant cleavage mechanisms and recent advances in the design of phosphonate prodrugs.

摘要

膦酸酯通常被用作磷酸盐的等排体替换物,可以与酶提供重要的相互作用。然而,由于其在生理 pH 下带高电荷,因此渗透进入细胞可能是一个挑战。将膦酸酯保护为前药已显示出在药物传递方面的应用前景。因此,存在各种结构和裂解/激活机制,能够释放活性化合物。本综述描述了这些前药基团的结构多样性、相关的裂解机制以及膦酸酯前药设计的最新进展。

相似文献

1
Phosphonate prodrugs: an overview and recent advances.膦酸酯前药:概述及最新进展。
Future Med Chem. 2019 Jul;11(13):1625-1643. doi: 10.4155/fmc-2018-0591.
2
[Application of phosphates and phosphonates prodrugs in drug research and development].[磷酸盐和膦酸盐前药在药物研发中的应用]
Yao Xue Xue Bao. 2013 May;48(5):621-34.
3
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.一系列细胞色素P(450) 3A激活的前药(肝靶向前药)的设计、合成及表征,这些前药可用于将基于磷酸(酯)的药物靶向输送至肝脏。
J Am Chem Soc. 2004 Apr 28;126(16):5154-63. doi: 10.1021/ja031818y.
4
Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: A versatile drug delivery paradigm.脂质缀合核苷单核苷酸和单膦酸酯前药:一种多功能药物传递范式。
Eur J Med Chem. 2024 Sep 5;275:116614. doi: 10.1016/j.ejmech.2024.116614. Epub 2024 Jun 22.
5
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity.两种嘧啶无环核苷膦酸酯的新型前药:合成与抗病毒活性。
Bioorg Med Chem. 2017 Sep 1;25(17):4637-4648. doi: 10.1016/j.bmc.2017.06.046. Epub 2017 Jul 6.
6
Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.(S)-3-(腺嘌呤-9-基)-2-(膦酰甲氧基)丙酸前药的合成及生物学性质
Eur J Med Chem. 2016 Jan 27;108:374-380. doi: 10.1016/j.ejmech.2015.12.009. Epub 2015 Dec 12.
7
Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs.脂肪族胺是膦酸酯药物中可行的前药部分。
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127656. doi: 10.1016/j.bmcl.2020.127656. Epub 2020 Oct 29.
8
Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery.用于药物递送的核苷酸类似物的对称二酰胺前药
Curr Protoc Nucleic Acid Chem. 2015 Mar 9;60:15.6.1-15.6.10. doi: 10.1002/0471142700.nc1506s60.
9
Design, synthesis, and antiviral activity of adenosine 5'-phosphonate analogues as chain terminators against hepatitis C virus.5'-膦酸腺苷类似物作为丙型肝炎病毒链终止剂的设计、合成及抗病毒活性
J Med Chem. 2005 Apr 21;48(8):2867-75. doi: 10.1021/jm049029u.
10
A prodrug approach towards the development of tricyclic-based FBPase inhibitors.将三环类化合物作为前药开发 FBPase 抑制剂的方法。
Bioorg Med Chem Lett. 2010 May 1;20(9):2938-41. doi: 10.1016/j.bmcl.2010.03.017. Epub 2010 Mar 7.

引用本文的文献

1
Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer.用于研究癌症中真核翻译起始因子4E(eIF4E)调控的翻译组的化学探针
ACS Pharmacol Transl Sci. 2025 Feb 17;8(3):621-635. doi: 10.1021/acsptsci.4c00674. eCollection 2025 Mar 14.
2
Biomimetic 1,2-amino migration via photoredox catalysis.通过光氧化还原催化实现的仿生1,2-氨基迁移
Nat Chem. 2025 Mar 7. doi: 10.1038/s41557-025-01775-2.
3
Synthesis and evaluation of triazole-containing aryl/acyloxy prodrugs of a BTN3A1 ligand.BTN3A1配体含三唑的芳基/酰氧基前药的合成与评价
Eur J Med Chem. 2025 Apr 5;287:117345. doi: 10.1016/j.ejmech.2025.117345. Epub 2025 Feb 1.
4
Discovery of Orally Available Prodrugs of Itaconate and Derivatives.衣康酸及其衍生物口服可用前体药物的发现。
J Med Chem. 2025 Feb 13;68(3):3433-3444. doi: 10.1021/acs.jmedchem.4c02646. Epub 2025 Jan 23.
5
Combating Bacterial Resistance by Polymers and Antibiotic Composites.聚合物与抗生素复合材料对抗细菌耐药性
Polymers (Basel). 2024 Nov 22;16(23):3247. doi: 10.3390/polym16233247.
6
Three-component enantioselective alkenylation of organophosphonates via nickel metallaphotoredox catalysis.通过镍金属光氧化还原催化实现有机膦酸酯的三组分对映选择性烯基化反应。
Chem. 2023 Jan 12;9(1):154-169. doi: 10.1016/j.chempr.2022.09.020. Epub 2022 Oct 14.
7
Supramolecular Binding of Phosphonate Dianions by Nanojars and Nanojar Clamshells.纳米罐和纳米罐蚌壳对膦酸二阴离子的超分子结合
Inorg Chem. 2024 Jul 29;63(30):14216-14230. doi: 10.1021/acs.inorgchem.4c02386. Epub 2024 Jul 18.
8
Development of a General Organophosphorus Radical Trap: Deoxyphosphonylation of Alcohols.一种通用有机磷自由基捕获剂的开发:醇的脱氧膦酰化反应
J Am Chem Soc. 2024 Mar 27;146(12):7942-7949. doi: 10.1021/jacs.4c00557. Epub 2024 Mar 12.
9
Accessing three-dimensional molecular diversity through benzylic C-H cross-coupling.通过苄基碳氢键交叉偶联获取三维分子多样性
Nat Synth. 2023 Oct;2(10):998-1008. doi: 10.1038/s44160-023-00332-4. Epub 2023 Jun 1.
10
Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir.基于阿德福韦类似物的 7-脱氮嘌呤的人 AC2 有效且选择性抑制剂的发现。
Bioorg Med Chem. 2023 Nov 15;95:117508. doi: 10.1016/j.bmc.2023.117508. Epub 2023 Oct 26.

本文引用的文献

1
Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane.前药激活中的反应性循环中间体:捕获难以捉摸的五价膦烷。
Org Biomol Chem. 2019 Jan 2;17(2):315-320. doi: 10.1039/c8ob02870b.
2
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.MEPicides:α,β-不饱和福司米丁类似物作为 DXR 抑制剂抗疟疾。
J Med Chem. 2018 Oct 11;61(19):8847-8858. doi: 10.1021/acs.jmedchem.8b01026. Epub 2018 Sep 24.
3
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.具有抗病毒活性的氨基磷酸酯和膦酰氨基甲酸酯(前药)。
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618775243. doi: 10.1177/2040206618775243.
4
The expanding role of prodrugs in contemporary drug design and development.前药在当代药物设计和开发中的作用不断扩大。
Nat Rev Drug Discov. 2018 Aug;17(8):559-587. doi: 10.1038/nrd.2018.46. Epub 2018 Apr 27.
5
USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.USC-087 可保护叙利亚仓鼠免受人类 C 型腺病毒的致死性攻击。
Antiviral Res. 2018 May;153:1-9. doi: 10.1016/j.antiviral.2018.03.001. Epub 2018 Mar 3.
6
The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis.甲基赤藓糖醇磷酸途径:对抗结核病中颇具前景的药物靶点
ACS Infect Dis. 2018 Mar 9;4(3):278-290. doi: 10.1021/acsinfecdis.7b00176. Epub 2018 Feb 8.
7
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.使用双膦酸盐前药扩增人γδ T细胞用于过继性免疫治疗。
Cancer Sci. 2018 Mar;109(3):587-599. doi: 10.1111/cas.13491. Epub 2018 Feb 4.
8
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.核苷类和非核苷类抗病毒药物的高级前药策略:对最近五年的综述。
Molecules. 2017 Oct 16;22(10):1736. doi: 10.3390/molecules22101736.
9
MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis.MEP 抑制剂:针对异戊烯基生物合成的强效抗疟前药。
Sci Rep. 2017 Aug 21;7(1):8400. doi: 10.1038/s41598-017-07159-y.
10
Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase.不对称无环核苷双膦酸盐作为恶性疟原虫和人次黄嘌呤 - 鸟嘌呤 -(黄嘌呤)磷酸核糖基转移酶抑制剂的合成与评价
J Med Chem. 2017 Sep 14;60(17):7539-7554. doi: 10.1021/acs.jmedchem.7b00926. Epub 2017 Aug 30.